Adalimumab Injection IP

Key Benefits
- Helps reduce inflammation associated with autoimmune conditions
- Supports management of rheumatoid and psoriatic arthritis
- Helps control symptoms of certain inflammatory bowel diseases
- Supports treatment of ankylosing spondylitis and related conditions
- Helps reduce skin inflammation and symptoms in plaque psoriasis
- May improve pain, swelling, stiffness, and other disease-related symptoms
How It Works
Adalimumab is a monoclonal antibody that specifically binds to tumor necrosis factor-alpha (TNF-α), an inflammatory protein involved in excessive immune system activity. By blocking TNF-α, it helps reduce inflammation and associated symptoms in susceptible inflammatory conditions.
Common Side Effects
- Injection-site redness, swelling, or pain
- Headache
- Nausea
- Upper respiratory tract infections
- Abdominal discomfort
- Fatigue
- Rash
Important Information
Adalimumab Injection IP should be used only under the supervision of a qualified healthcare professional. Because it suppresses part of the immune system, it may increase the risk of serious infections, including tuberculosis and other opportunistic infections. Patients may require screening for tuberculosis and hepatitis B before treatment. Live vaccines should generally be avoided during therapy unless specifically advised by a healthcare professional. Seek medical attention for persistent fever, severe infection symptoms, breathing difficulty, or signs of an allergic reaction.